New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2013
08:40 EDTROSGRosetta Genomics reports first payment from UK NHS for Cancer Origin Test
Rosetta Genomics announces that the National Health Service, or NHS, of the United Kingdom, has made its first payment to the company for use of the Rosetta Cancer Origin Test on a British citizen. The accurate identification of the primary tumor type in primary and metastatic cancer including cancer of unknown or uncertain primary is important in guiding clinician treatment decisions to maximize patient outcomes.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
08:31 EDTROSGRosetta Genomics receives U.S. patent allowance for kidney cancer test
Subscribe for More Information
March 25, 2015
08:02 EDTROSGRosetta Genomics to launch Admera's OncoGxOne
Subscribe for More Information
March 17, 2015
08:24 EDTROSGRosetta Genomics to host conference call
Conference call to provide corporate and financial updates will be held on March 17 at 10 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use